| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Retension Pharmaceuticals (NASDAQ:RTSN) through any online brokerage.
There are no as such competitors for Retension Pharmaceuticals.
There is no analysis for Retension Pharmaceuticals to provide a consensus price target.
The stock price for Retension Pharmaceuticals (NASDAQ: RTSN) is $13.94 last updated October 16, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Retension Pharmaceuticals.
Retension Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Retension Pharmaceuticals.
Retension Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral,...